New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer

Clinical Nuclear Medicine

Volumn 38, Issue 1, 2013, Pages 7-12

  Yoon, Hai Jeon ^a   Kim, Seok Ki ^a   Kim, Tae Sung ^a   Im, Hyung Jun ^a   Lee, Eun Seong ^a   Kim, Hyun Chul ^a   Park, Ji Won ^a   Chang, Hee Jin ^a   Choi, Hyo Seong ^a   Kim, Dae Yong ^a   Oh, Jae Hwan ^a  

^a National Cancer Center   (South Korea)

Author keywords

DI; dual point PET CT; Dworak tumor regression grade; neoadjuvant chemoradiotherapy; rectal cancer

Indexed keywords

CAPECITABINE; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; UFT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CHEMORADIOTHERAPY; CLINICAL PROTOCOL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DWORAK TUMOR REGRESSION GRADE; FEMALE; GOLD STANDARD; HUMAN; IMAGING SYSTEM; LOCALLY ADVANCED RECTAL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RECTUM CANCER; RECTUM SURGERY; SENSITIVITY AND SPECIFICITY; SURGICAL APPROACH; TREATMENT RESPONSE;

CHEMORADIOTHERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RECTAL NEOPLASMS; ROC CURVE; TREATMENT OUTCOME;

EID: 84871654740     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182639a58     Document Type: Article

References (33)

1. Valentini M. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys. 1998;40:1067-1075.
2. Chen ET, Mohiuddin M, Brodovsky H, et al. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys. 1994;30:169-175. (Pubitemid 24291127)
3. Minsky B, Cohen A, Enker W, et al. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys. 1997;37:289-295. (Pubitemid 27138711)
4. Rich T, Skibber J, Ajani J, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys. 1995;32:1025-1029.
5. Janjan NA, Crane CN, Feig BW, et al. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2000;47:713-718. (Pubitemid 30317490)
6. Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, et al. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum. 2003;46:298-304. (Pubitemid 36331646)
7. Ruo L, Tickoo S, Klimstra D, et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg. 2002;236:75-81. (Pubitemid 34686453)
8. Rengan R, Paty PB, Wong WD, et al. Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders. Clin Colorectal Cancer. 2006;5:413-421.
9. Habr-Gama A, Perez R, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240:711-718. (Pubitemid 39281293)
10. Brucher B, Weber W, Bauer M, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg. 2001;233:300-309. (Pubitemid 32187807)
11. Flamen P, Van Cutsem E, Lerut A, et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol. 2002;13:361-368. (Pubitemid 34704995)
12. Jones D, McCowage G, Sostman H, et al. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med. 1996;37:1438-1444. (Pubitemid 26321617)
13. 18F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol. 2000;18:1676-1688. (Pubitemid 30220546)
14. Amthauer H, Denecke T, Rau B, et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Eur J Nucl Med. 2004;31:811-819. (Pubitemid 38758350)
15. Denecke T, Rau B, Hoffmann K, et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging? Eur Radiol. 2005;15:1658-1666. (Pubitemid 41102362)
16. Melton GB, Lavely WC, Jacene HA, et al. Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg. 2007;11:961-969.
17. Capirci C, Rampin L, Erba P, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med. 2007;34:1583-1593. (Pubitemid 47476915)
18. 18F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging. Int J Radiat Oncol Biol Phys. 2010;77:392-399.
19. Rosenberg R, Herrmann K, Gertler R, et al. The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT. Int J Colorectal Dis. 2009;24:191-200.
20. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med. 1991;32:1485-1490.
21. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med. 2006;47:1241-1248. (Pubitemid 47544874)
22. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12:19-23. (Pubitemid 27138353)
23. Park JW, Lim SB, Kim DY, et al. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery. Int J Radiat Oncol Biol Phys. 2009;74:810-817.
24. Lodge M, Lucas J, Marsden P, et al. APET study of 18 FDG uptake in soft tissue masses. Eur J Nucl Med. 1999;26:22-30. (Pubitemid 29137735)
25. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412-1417. (Pubitemid 32852620)
26. Boerner A, Weckesser M, Herzog H, et al. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med. 1999;26:226-230. (Pubitemid 29139852)
27. Yamada S, Kubota K, Kubota R, et al. High accumulation of fluorine-18- fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301-1306.
28. Guillem J, Moore H, Akhurst T, et al. Sequential preoperative fluorodeoxyglucose- positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg. 2004;199:1-7. (Pubitemid 38813288)
29. Stone HB, Coleman CN, Anscher MS, et al. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 2003;4:529-536. (Pubitemid 38351709)
30. Greven KM, Williams DW 3rd, McGuirt WF Sr, et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck. 2001;23:942-946. (Pubitemid 32977536)
31. Hung GU, Lee KW, Liao PY, et al. The influence of I-131 therapy on FDG uptake in differentiated thyroid cancer. Ann Nucl Med. 2008;22:481-485.
32. 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med. 2004;34:122-133. (Pubitemid 38375467)
33. Schoder H, Yeung HW. Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med. 2004;34:180-197. (Pubitemid 38887174)